Compare LFST & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LFST | HTGC |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | United States | United States |
| Employees | N/A | 50 |
| Industry | Medical/Nursing Services | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.9B |
| IPO Year | 2021 | N/A |
| Metric | LFST | HTGC |
|---|---|---|
| Price | $10.10 | $15.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $9.83 | ★ $18.86 |
| AVG Volume (30 Days) | ★ 2.8M | 1.3M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 12.13% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $1,424,285,000.00 | N/A |
| Revenue This Year | $17.18 | $11.18 |
| Revenue Next Year | $14.02 | $5.24 |
| P/E Ratio | ★ N/A | $8.61 |
| Revenue Growth | ★ 13.85 | N/A |
| 52 Week Low | $3.74 | $13.70 |
| 52 Week High | $10.00 | $19.67 |
| Indicator | LFST | HTGC |
|---|---|---|
| Relative Strength Index (RSI) | 78.65 | 51.06 |
| Support Level | $6.23 | $15.22 |
| Resistance Level | N/A | $15.89 |
| Average True Range (ATR) | 0.33 | 0.29 |
| MACD | 0.17 | -0.01 |
| Stochastic Oscillator | 97.66 | 60.87 |
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.